It is a pharma private limited company based in Mira Road, Maharashtra, India, established in 2005.
2005 | Mira Road, Maharashtra, India | ActiveCandaur Pharmaceuticals Private Limited, a active private limited company, was established on 28 June 2005 in Mira Road, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2005PTC154284. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.20 M.
It upholds a compliant status. Its leadership includes Supriya Mohanty (Director), Manas Ranjan Patnaik (Director), Pragyan Paramita Patnaik (Director). Past directors included Neetu Sabarwal, Imran Akbar Rizvi, Geetika Gupta. It holds ₹1.64 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No 17, Iris Building, Jangir Enclave, Beverly Park, Mira Road (E), Mira Road, Maharashtra, 401107.
U24230MH2005PTC154284
154284
28 June 2005
₹2.50 M
₹2.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Candaur Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Supriya Mohanty | Director | 01 Jul 2015 | Current |
| Manas Ranjan Patnaik | Director | 01 Jul 2005 | Current |
| Pragyan Paramita Patnaik | Director | 01 Jul 2005 | Current |
| Geetika Gupta | Additional Director | 16 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Apr 2020 | Past |
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Additional Director | 31 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Candaur Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.2% increase. The company also saw a substantial improvement in profitability, with a 45.24% increase in profit. The company's net worth Soared by an impressive increase of 11.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Candaur Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹16,422,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2014 | Others | ₹1.64 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Candaur Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Candaur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Candaur Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Candaur Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Candaur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge with Others of Rs. 16.42 M registered on 15 Mar 2014 with Charge ID 10500640 was modified on 18 May 2023. was recorded as a recent event.
The activity Geetika Gupta was appointed as a Additional Director was appointed as a Additional Director on 16 Mar 2018 & has been associated with this company since 7 years 8 months . was completed.
Progress on Supriya Mohanty was appointed as a Director was appointed as a Director on 01 Jul 2015 & has been associated with this company since 10 years 5 months . was documented.
The activity A charge with Others amounted to Rs. 16.42 M with Charge ID 10500640 was registered on 15 Mar 2014. was completed.
The CIN of Candaur Pharmaceuticals Private Limited is U24230MH2005PTC154284.
Candaur Pharmaceuticals Private Limited is headquartered at Shop No 17, Iris Building, Jangir Enclave, Beverly Park, Mira Road (E), Mira Road, Maharashtra, 401107.
Candaur Pharmaceuticals Private Limited was incorporated on 28 June 2005.
The current directors of Candaur Pharmaceuticals Private Limited are
The primary industry of Candaur Pharmaceuticals Private Limited is Trade.
Candaur Pharmaceuticals Private Limited is unlisted.
The authorized capital of Candaur Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.20 M.
The compliance status of Candaur Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX